OpenLB
Open Library of Bioscience
Advanced Search
Gland surgery
Oct, 2016;5 (5): 506-511.

Perioperative hemodynamic instability in patients undergoing laparoscopic adrenalectomy for pheochromocytoma.

Magdalena Pisarska, Michał Pędziwiatr, Andrzej Budzyński
Author Information
  1. Magdalena Pisarska: 2 Department of General Surgery, Jagiellonian University Medical College, Kraków, Poland;; Department of Endoscopic, Metabolic and Soft Tissue Tumors Surgery, Kraków, Poland.
  2. Michał Pędziwiatr: 2 Department of General Surgery, Jagiellonian University Medical College, Kraków, Poland;; Department of Endoscopic, Metabolic and Soft Tissue Tumors Surgery, Kraków, Poland.
  3. Andrzej Budzyński: 2 Department of General Surgery, Jagiellonian University Medical College, Kraków, Poland;; Department of Endoscopic, Metabolic and Soft Tissue Tumors Surgery, Kraków, Poland.
PMID: 27867865 DOI: 10.21037/gs.2016.09.05

Abstract

Perioperative hemodynamic instability still remains the biggest surgical and anesthetic challenge in surgery for pheochromocytoma. The aim of this review was to discuss pre-, intra- and postoperative factors that may impact on hemodynamic condition of a patient. It describes patients' preparation with appropriate medication, principles of surgical technique as well as risk factors for development of hemodynamic instability in postoperative period. Currently the gold standard in the treatment of pheochromocytoma is preoperative use of alpha-blockers and laparoscopic surgery. This approach allowed improving outcomes by lowering both mortality and morbidity.

Keywords

Laparoscopy adrenalectomy hemodynamic instability pheochromocytoma

References

  1. World J Surg. 2002 Aug;26(8):1037-42 [PMID: 12192533]
  2. World J Surg. 1999 Apr;23(4):389-96 [PMID: 10030863]
  3. Surgery. 1982 Apr;91(4):367-73 [PMID: 6801796]
  4. Urology. 1997 May;49(5):673-8 [PMID: 9145969]
  5. Am J Hypertens. 1996 Aug;9(8):760-9 [PMID: 8862222]
  6. JAMA. 2002 Mar 20;287(11):1427-34 [PMID: 11903030]
  7. Surgery. 1996 Dec;120(6):1076-9; discussion 1079-80 [PMID: 8957498]
  8. Urol Int. 2016;97(2):165-72 [PMID: 26963130]
  9. Ann Surg. 1990 Nov;212(5):621-8 [PMID: 1978640]
  10. Br J Surg. 2010 May;97(5):754-8 [PMID: 20235087]
  11. Gland Surg. 2015 Aug;4(4):279-82 [PMID: 26312212]
  12. Surg Endosc. 2002 Jan;16(1):100-2 [PMID: 11961615]
  13. Anesth Analg. 2000 Nov;91(5):1118-23 [PMID: 11049893]
  14. J Urol. 1999 Mar;161(3):764-7 [PMID: 10022680]
  15. Acta Anaesthesiol Scand. 2009 Apr;53(4):522-7 [PMID: 19239408]
  16. Surgery. 2013 Jan;153(1):111-9 [PMID: 22939744]
  17. Hypertension. 2010 Mar;55(3):600-6 [PMID: 20083723]
  18. Urology. 2000 Mar;55(3):339-43 [PMID: 10699606]
  19. Best Pract Res Clin Endocrinol Metab. 2006 Sep;20(3):483-99 [PMID: 16980207]
  20. Cleve Clin J Med. 1990 Oct;57(7):613-7 [PMID: 2121390]
  21. Br J Anaesth. 1984 Jul;56(7):781-9 [PMID: 6375708]
  22. Arch Intern Med. 2000 Sep 11;160(16):2521-4 [PMID: 10979065]
  23. Wideochir Inne Tech Maloinwazyjne. 2015 Sep;10(3):466-71 [PMID: 26649097]
  24. BMC Surg. 2015 Aug 28;15:101 [PMID: 26314582]
  25. Anaesthesia. 2005 May;60(5):439-44 [PMID: 15819762]
  26. Gland Surg. 2015 Aug;4(4):350-8 [PMID: 26310999]
  27. J Clin Endocrinol Metab. 2010 Feb;95(2):678-85 [PMID: 19965926]
  28. Surg Endosc. 2013 Nov;27(11):3960-80 [PMID: 24018761]
  29. Ann Surg Oncol. 2014 Nov;21(12):3865-71 [PMID: 24939623]
  30. Clin Med Res. 2004 Feb;2(1):59-62 [PMID: 15931336]
  31. Surg Endosc. 1999 Jan;13(1):35-9 [PMID: 9869685]
  32. Drugs. 1981 Feb;21(2):81-9 [PMID: 7009139]
  33. J Hum Hypertens. 2009 Sep;23(9):605-9 [PMID: 19225531]
  34. Gland Surg. 2015 Oct;4(5):435-41 [PMID: 26425457]
  35. Ann Surg. 1999 Jun;229(6):755-64; discussion 764-6 [PMID: 10363888]
  36. Eur Urol. 2014 Jun;65(6):1154-61 [PMID: 24079955]
  37. Br Med J. 1967 Jan 28;1(5534):191-8 [PMID: 4381157]
  38. J Lab Clin Med. 1990 Apr;115(4):449-53 [PMID: 1969915]
  39. N Engl J Med. 1992 Oct 1;327(14):1033 [PMID: 1387700]
  40. Surgery. 2016 Mar;159(3):763-70 [PMID: 26477475]
  41. Can J Anaesth. 2002 Dec;49(10):1099-100 [PMID: 12477689]
  42. J Clin Endocrinol Metab. 2007 Nov;92(11):4069-79 [PMID: 17989126]
  43. Int J Endocrinol. 2014;2014:658483 [PMID: 24817886]
  44. Int J Surg. 2015 Aug;20:88-94 [PMID: 26074291]
  45. Anesthesiology. 1954 Nov;15(6):658-65 [PMID: 13207794]
  46. BJU Int. 2009 Jan;103(2):218-22 [PMID: 18671788]
  47. Eur J Endocrinol. 2011 Sep;165(3):365-73 [PMID: 21646289]
  48. Br J Anaesth. 2004 Apr;92(4):512-7 [PMID: 14766711]
  49. J Anaesthesiol Clin Pharmacol. 2015 Jul-Sep;31(3):317-23 [PMID: 26330708]
  50. Br J Surg. 2004 Oct;91(10):1259-74 [PMID: 15376201]
  51. Surgeon. 2010 Feb;8(1):9-14 [PMID: 20222397]
  52. Circulation. 1956 Oct;14(4 Part 1):622-30 [PMID: 13365067]
  53. Anesth Analg. 1999 Jan;88(1):16-21 [PMID: 9895059]
  54. Arch Intern Med. 1997 Apr 28;157(8):901-6 [PMID: 9129550]
  55. Gland Surg. 2015 Aug;4(4):277-8 [PMID: 26311226]
Review Journal Article

Word Cloud

Created with Highcharts 10.0.0hemodynamicinstabilitypheochromocytomaPerioperativesurgicalsurgerypostoperativefactorslaparoscopicadrenalectomystillremainsbiggestanestheticchallengeaimreviewdiscusspre-intra-mayimpactconditionpatientdescribespatients'preparationappropriatemedicationprinciplestechniquewellriskdevelopmentperiodCurrentlygoldstandardtreatmentpreoperativeusealpha-blockersapproachallowedimprovingoutcomesloweringmortalitymorbiditypatientsundergoingLaparoscopy

Similar Articles

Cited By